Antibodies eluted from homogenates of human mela noma cells reacted against melanoma antigens in a comple ment fixation test. Before elution, sonically treated homoge nate did not react significantly against autologous serum but, following elution, antigenic activity increased markedly (up to 32-fold). Eluate of one melanoma reacted with the sonically treated residue of other melanomas but not with similarly prepared residues of sarcoma, carcinomas, or normal tissues. Melanoma eluates contained more IgG than IgA. Traces of 1gM were found in two melanoma eluates.
INTRODUCTION

Antitumor
antibodies that react with human tumor antigens prepared from biopsy tumor tissues and cultured human tumor cells have been demonstrated in the sera of cancer patients by a variety of in vitro immunological techniques (2, 3, 6, 11, 13, 17, 18, 29) . Ifsuch antigen/anti body reactions occur in vivo, one would expect to find these antibodies on tumor cells obtained from biopsy and autopsy materials.
Although immunoglobulins have been eluted from human and animal tumors by many investigators, the immunological reactivity of these immunoglobulin prepara tions has not been clearly established in human systems (15, 16, 21, 22, 26, 27, 28 ).
Eilber and Morton (8) showed that antisarcoma anti bodies could be occasionally eluted from the biopsy tissue of human sarcomas. Subsequently, Phillips and Lewis (20) suggested that immunogiobulins having specific an timelanoma activity could be eluted from human melanoma cells. These results implied an in vivo reaction between serum antibodies and the antigens on the tumor cells.
This investigation was undertaken to determine whether antibodies could be eluted consistently from human malig nant melanoma tissues and to determine the antitumor specificities of such antibodies.
MATERIALS AND METHODS
Tumorous and Normal Tissues
Melanoma, sarcoma, and carcinoma tissues obtained at biopsy or autopsy were either processed immediately for elution of antibodies or quick frozen in liquid nitrogen and stored until used. Normal tissues (muscle, kidney and lung) were obtained at autopsy from patients who expired from causes other than cancer and were processed in a like manner.
Elution of Antibodies
In order to determine the most efficient method for antibody elution, a human melanoma (Patient C. F.) tissue specimen (@20 g net weight) was cleaned thoroughly to remove all connective and adipose tissues. The tumor was minced finely and passed through a 60 mesh screen. The tissue that did not go through the screen was discarded. The cells obtained from the screening were washed 15 times with 9 to 10 volumesof PBS2or until the final washhad an absorbance below 0.025 at 280 nm. The cells were weighed (@ 10 g net weight) and resuspended in 40 ml PBS to achieve a 20% (w/v) cell suspension. After I aliquot was removed, the remaining suspension was equally divided into 5 gradu ated conical centrifuge tubes marked A through E, and centrifuged at 2500 rpm in a GLC-l centrifuge (Sorvall, Inc., Newton, Conn.) at room temperature for 10 mm. The supernatants were discarded and the packed cells were treated as follows.
Tube A. Cells were resuspended in 9 volumes of PBS (pH 7.4) and exposed to 56Â°for 1.0 hr with intermittent shaking and then were centrifuged (Microfuge, Fisher Scientific Co., Pittsburgh, Pa.) at high speed for 30 mm. Supernatant and sediment were saved.
Tube B. Cells were resuspended in 9 volumes of 15% NaCl solution (pH 7.4), incubated at 4Â°with intermittent shaking, and centrifuged at 10,000 x g for 10 mm. volumes of PBS, resuspended in PBS (20% v/v), and sonically disrupted at low frequency to form a fine suspen sion. These suspensions were used as antigens and are hereafter called â€oesonically treated residue.â€• The aliquot of cell suspension saved before the various treatments was adjusted to 20% (v/v) in PBS and treated sonically as described above. This suspension was desig nated as the homogenate (before elution) and was also used as antigen.
The protein concentration in the 1st 5 eluates ranged from 15 to 20 mg/mI as determined by 280 to 260 nm absorption ratio. The protein concentration in the low-pH eluate was 8 mg/mi. In the 1st 5 eluates, the IgG was determined as 0.4 to 0.6 mg/ml and 1gM at trace quantities ( @0.005 mg/mi) by the radial immunodiffusion method. The IgG concentra tion in the low-pH eluate was @0.3 mg/mi. Results (Table I) indicated that, although all the eluates contained IgG in measurable quantities and 1gM in trace quantities, the low-pH eluate did not contain antibody activity by complement fixation against any sonically treated residues, whereas eluates of Procedures A through D showed complement-fixing antibody activity against all sonically treated residues, including the residue of low-pH treatment.
As seen in Table 1 , active antibody elution was accom pushed most efficiently by exposing the tumor cells to 15%
NaCI solution at 37Â°. This particular procedure, with modifications as outlined in Chart I, was followed routinely thereafter to process 4 additional melanomas, 3 carcinomas, 1 sarcoma, and 3 specimens of normal tissues.
Immunological Techniques
Antibody activity of the eluates and antigenic activity of the sonically treated residues were determined by an ultramicrocomplement fixation test described by Colom bani et al. (4) . Essentially, the procedures were the same as those of the conventional microcomplement fixation test developed by Sever (23) and adapted by Eilber and Morton (9, 10) for tumor-antitumor systems except that the total volume/well was 8 @ilinstead of 25 @sl. Because the volume/well was so small, the tests were performed in Before eiution, the homogenate from this melanoma speci men did not react significantly with autologous serum and not at all with homologous sera. Following elution with 15% NaCI solution, the sonically treated residue showed anti genic activity against both the eluted antibodies and with autologous serum antibodies, but had lower reactivity with homologous serum antibodies. Additional experiments were done on melanoma tissue specimens from 4 patients (S. N., M. M., R. C., and F. H.) to determine whether 1st, the eluted antibodies would cross-react with the sonically treated residues; 2nd, the antibodies would react with sonically treated residues of 3 carcinomas (M. A., P. R., and A. G), 1 sarcoma (F. C.); or 3rd, with 3 normal tissue specimens of muscle, lung, and kidney obtained at autopsy from a patient who expired from a nonmalignant cause. These results are presented in Table  3 . Eluted antibody dilutions from 4 melanomas (S. N., M. M., C. F., and R. C.) were standardized at 1:10 because each was anticomplementary in the undiluted state. The eluted antibodies from the 5 melanomas reacted with autologous and/or homologous sonicaily treated tumor residues. The eluates did not react with sonically treated residue of the sarcoma, the 3 carcinomas, or the 3 normal tissues, nor did the eluates of the carcinomas, sarcoma, and normal tissues react with the sonically treated residues of the 5 melanomas. One melanoma residue (R. C.) did not react with any of the eluted antibodies; however, antibodies from R. C. did react with the melanoma residues of M. M. and C. F.
Analyses of the eluates by immunodiffusion and immuno electrophoresis
with specific antiserum to human immuno globulins are shown in Microtest Plates (Falcon Plastics, Los Angeles, Calif.), and a layer of mineral oil was placed over the reagents to prevent evaporation during incubation. Two sl of appropri ate dilutions of antigen and antibody were placed in each of the wells with 2 units of complement. Fresh human umbilical cord serum was used as the source of complement (7) . Two @tl of 0.5% sensitized sheep red blood cells per well were used as the indicator system. Each test plate was controlled internally as well as externally. The internal controls included a complement titration with and without antigen, a buffer control, and a control for sheep red blood cells representing 100, 50, and 0% hemolysis. The external control was maintained using a cancer patient's serum known to be positive and a normal serum known to be negative against a human melanoma antigen of known antigenicity.
Eluates of tumors and normal tissues were also analyzed for serum proteins by microimmunodiffusion and immuno electrophoresis.
The immunodiffusion technique of Ouch terlony (19) was adapted for microplates (5) , by using 1% agar gel made in 0.85% NaC1 solution at pH 7.0 to 7.4. Table 4 Detection oflgG, IgA , and 1gM in eluates ofhuman tumors and normal tissues by immunodiffusion and immunoelectrophoresis using monospecific antisera elution procedure and that active antigen and antibody were recovered separately. The recovered antibodies were proba bly similar to serum antibodies because the antigen titers of the sonically treated residues increased against both autolo gous serum and the eluted antibodies. In addition to the free antibodies, the eiuates may have contained antigen-anti body complexes because some of the eluates were anticom piementary in their undiluted state. This possibility is under investigation.
RESULTS
Antitumor Antibodies from Human Malignant Melanomas
It seems likely that the immunoglobulins demonstrated on biopsy specimens by Thunold et al. (27) were in fact antitumor antibodies. Since the antibodies eiuted from human melanoma tissues are complement fixing, they may be directly cytotoxic in vivo; however, their significance in terms of tumor-host relationship, whether they play a role in blocking or augmenting cell-mediated immunity (12, 14, 24, 25) , remains to be determined.
Apparently, there was a common antigen responsible for the reactivity among the melanomas, because 2 of the melanoma residues (M. M. and C. F.) reacted with antibodies eiuted from all 5 melanomas (Table 3) . However, the pattern of reactivity between the eluted antibodies a@nd sonically treated residues suggested that antigens of more limited specificity were also present, because 2 residues (S. N. and F. H.) reacted only to their autologous eluted antibodies and to C. F. antibody.
The results ( Table 3 ) also show that the amount of immunologically active antibody that could be eluted from melanoma tissues varied from patient to patient. The eluted antibodies of C. F. and S. N. were the strongest reactors by These immunological reactions between eluted antibodies and melanoma residues cannot be explained by isoantibody activity against histocompatibility (ilL-A and blood group) antigens in the melanoma tissue because the antibody eluted from each patient's melanoma reacted with his correspond ing autologous melanoma residue. Many of these eluted antibodies reacted with other melanomas but did not react against sonicaily treated residues of other histological types of neoplasms or normal tissues, nor did the eluate of the other neoplasms or normal tissue react against the sonically treated residues of melanoma. If the observed reactivities between eluted melanoma antibodies and sonically treated residues of melanoma were due to histocompatibility anti gens, some reactivity between the antibodies eluted from melanoma and these other types of tissue residues would have been expected. Therefore, it would appear that the human malignant melanomas certainly contain cell surface antigens which may react with antimelanoma antibodies in vivo.
